微生物群对非酒精性脂肪性肝病和非酒精性脂肪性肝炎的影响。
The Influence of the Microbiome on NAFLD and NASH.
作者信息
Albhaisi Somaya A M, Bajaj Jasmohan S
机构信息
Department of Internal Medicine Virginia Commonwealth University Richmond VA.
Division of Gastroenterology, Hepatology, and Nutrition Department of Internal Medicine Virginia Commonwealth University and McGuire VA Medical Center Richmond VA.
出版信息
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):15-18. doi: 10.1002/cld.1010. eCollection 2021 Jan.
Abstract
Watch a video presentation of this article Watch an interview with the author.
摘要
观看本文的视频演示。观看对作者的采访。
相似文献
1
The Influence of the Microbiome on NAFLD and NASH.
Clin Liver Dis (Hoboken). 2021 Feb 1;17(1):15-18. doi: 10.1002/cld.1010. eCollection 2021 Jan.
2
Non-alcoholic fatty liver and the gut microbiota.
Mol Metab. 2016 Jun 14;5(9):782-94. doi: 10.1016/j.molmet.2016.06.003. eCollection 2016 Sep.
3
Microbiome and NAFLD: potential influence of aerobic fitness and lifestyle modification.
Physiol Genomics. 2017 Aug 1;49(8):385-399. doi: 10.1152/physiolgenomics.00012.2017. Epub 2017 Jun 9.
4
Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
Gastroenterology. 2019 Oct;157(4):1109-1122. doi: 10.1053/j.gastro.2019.06.028. Epub 2019 Jun 27.
5
Gut microbiome and nonalcoholic fatty liver diseases.
Pediatr Res. 2015 Jan;77(1-2):245-51. doi: 10.1038/pr.2014.157. Epub 2014 Oct 13.
6
Review article: can bugs be drugs? The potential of probiotics and prebiotics as treatment for non-alcoholic fatty liver disease.
Aliment Pharmacol Ther. 2019 Sep;50(6):628-639. doi: 10.1111/apt.15416. Epub 2019 Aug 2.
7
The role of the microbiome in NAFLD and NASH.
EMBO Mol Med. 2019 Feb;11(2). doi: 10.15252/emmm.201809302.
8
Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications.
Aliment Pharmacol Ther. 2019 Jul;50(2):144-158. doi: 10.1111/apt.15314. Epub 2019 May 31.
9
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.
Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525.
10
The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD.
Diseases. 2019 Feb 25;7(1):27. doi: 10.3390/diseases7010027.
引用本文的文献
1
Deep sequencing-derived Metagenome Assembled Genomes from the gut microbiome of liver transplant patients.
Sci Data. 2025 Jan 9;12(1):39. doi: 10.1038/s41597-024-04153-8.
2
The influence of perilipin 5 deficiency on gut microbiome profiles in murine metabolic dysfunction-associated fatty liver disease (MAFLD) and MAFLD-hepatocellular carcinoma.
Front Cell Infect Microbiol. 2024 Oct 14;14:1443654. doi: 10.3389/fcimb.2024.1443654. eCollection 2024.
3
Metabolic dysfunction-associated steatotic liver disease exhibits sex-specific microbial heterogeneity within intestinal compartments.
Clin Mol Hepatol. 2025 Jan;31(1):179-195. doi: 10.3350/cmh.2024.0359. Epub 2024 Oct 11.
4
Nonalcoholic steatohepatitis: A comprehensive updated review of risk factors, symptoms, and treatment.
Heliyon. 2024 Mar 25;10(7):e28468. doi: 10.1016/j.heliyon.2024.e28468. eCollection 2024 Apr 15.
5
Microbial Dysbiosis Linked to Metabolic Dysfunction-Associated Fatty Liver Disease in Asians: Promotes Lipopolysaccharide Biosynthesis and Network Instability in the Prevotella Enterotype.
Int J Mol Sci. 2024 Feb 11;25(4):2183. doi: 10.3390/ijms25042183.
6
NASH/NAFLD-Related Hepatocellular Carcinoma: An Added Burden.
Life (Basel). 2023 Dec 23;14(1):25. doi: 10.3390/life14010025.
7
Immunology of gut microbiome and liver in non-alcoholic fatty liver disease (NAFLD): mechanisms, bacteria, and novel therapeutic targets.
Arch Microbiol. 2024 Jan 13;206(2):62. doi: 10.1007/s00203-023-03752-0.
8
Exploring public interest in gut microbiome dysbiosis, NAFLD, and probiotics using Google Trends.
Sci Rep. 2024 Jan 8;14(1):799. doi: 10.1038/s41598-023-50190-5.
9
Alanyl-Glutamine Dipeptide Attenuates Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice by Improving Gut Microbiota Dysbiosis.
Nutrients. 2023 Sep 14;15(18):3988. doi: 10.3390/nu15183988.
10
- A Potential Next-generation Probiotic for Non-alcoholic Fatty Liver Disease.
Curr Pharm Biotechnol. 2024;25(4):426-433. doi: 10.2174/1389201025666230915103052.
本文引用的文献
1
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial.
Lancet. 2019 Dec 14;394(10215):2184-2196. doi: 10.1016/S0140-6736(19)33041-7. Epub 2019 Dec 5.
2
Role of gut microbiota in liver disease.
Am J Physiol Gastrointest Liver Physiol. 2020 Jan 1;318(1):G84-G98. doi: 10.1152/ajpgi.00118.2019. Epub 2019 Oct 28.
3
A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease.
Nat Commun. 2019 Mar 29;10(1):1406. doi: 10.1038/s41467-019-09455-9.
4
FXR-Dependent Modulation of the Human Small Intestinal Microbiome by the Bile Acid Derivative Obeticholic Acid.
Gastroenterology. 2018 Dec;155(6):1741-1752.e5. doi: 10.1053/j.gastro.2018.08.022. Epub 2018 Aug 23.
5
Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease.
Cell Metab. 2017 May 2;25(5):1054-1062.e5. doi: 10.1016/j.cmet.2017.04.001.
6
Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.
Hepatology. 2017 Jan;65(1):350-362. doi: 10.1002/hep.28709. Epub 2016 Aug 4.
7
Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats.
J Hepatol. 2016 May;64(5):1049-1057. doi: 10.1016/j.jhep.2015.12.010. Epub 2015 Dec 23.
8
Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus.
Sci Rep. 2015 Dec 22;5:18559. doi: 10.1038/srep18559.
9
The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota.
Hepatology. 2016 Mar;63(3):764-75. doi: 10.1002/hep.28356. Epub 2016 Jan 13.
10
MyD88 Adaptor-Dependent Microbial Sensing by Regulatory T Cells Promotes Mucosal Tolerance and Enforces Commensalism.
Immunity. 2015 Aug 18;43(2):289-303. doi: 10.1016/j.immuni.2015.06.014. Epub 2015 Jul 28.
Zotero 插件